Pharmacoepidemiology
2025 Activity indicators
- 1 competitive national public project: ISCIII
- 2 private projects led
- 1 contract with a public agency led: AEMPS
- 1 competitive HR contract
- 2 publications
- FI: 20.50
- Publications in Q1: 2 (100%)
- Publications in D1: 1 (50%)
- Reviewers at national institutions: 4 researchers
- Editorial board members: 1 PI
- 6.5-month stay at an international center: CAUSALab - Harvard T.H. School of Public Health, U.S.
Milestones
- Collaboration with CausaLab - Harvard TH Chan School of Public Health.
- Direction, coordination, and editing of the book *Treatise on Pharmacoepidemiology and Pharmacovigilance* - UAH Press (to be published in May 2026).
- Organization of the 7th PIELenRed Multidisciplinary Conference on Serious Drug-Induced Skin Reactions-Celebration of the 15th anniversary of the PIELenRed Consortium.
- Sara Rodríguez Martín was elected a member of the Scientific Committee of the Database for Pharmacoepidemiological Research in Primary Care (BIFAP), part of the AEMPS.
- Studies on the eradication of Helicobacter pylori infection in primary care (BIFAP)-Presentations at the 45th Congress of the Spanish Society of Family and Community Medicine (semFYC).
Bibliometrics
| Articles | Accum. FI | Mean | Articles Q1 or Q2 | % in Q1 or Q2 | Articles D1 | % in D1 | |
|---|---|---|---|---|---|---|---|
| 2021 | 3 | 18.55 | 6.18 | 3 | 100 | 2 | 67 |
| 2022 | 11 | 62.89 | 5.72 | 9 | 82 | 2 | 18 |
| 2023 | 7 | 35.70 | 5.10 | 7 | 100 | 1 | 14 |
| 2024 | 4 | 15.60 | 3.90 | 4 | 100 | 0 | 0 |
| 2025 | 2 | 20.50 | 10.25 | 2 | 100 | 1 | 50 |
| 27 | 153.24 | 5.23 | 25 | 96 | 6 | 30 |
* Only original articles, editorials, guidelines & reviews
